Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
64.2M
-
Shares change
-
+3.07M
-
Total reported value, excl. options
-
$2.86B
-
Value change
-
+$127M
-
Put/Call ratio
-
0.23
-
Number of buys
-
104
-
Number of sells
-
-99
-
Price
-
$44.61
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q1 2020
249 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q1 2020.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.2M shares
of 79.2M outstanding shares and own 80.99% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (6.24M shares), VANGUARD GROUP INC (5.58M shares), FRANKLIN RESOURCES INC (5.52M shares), BlackRock Inc. (5.13M shares), FMR LLC (4.88M shares), RTW INVESTMENTS, LP (3.93M shares), STATE STREET CORP (2.37M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.05M shares), JANUS HENDERSON GROUP PLC (1.77M shares), and GREAT POINT PARTNERS LLC (1.76M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.